Summary & Overview
CPT 81371: HLA-A, HLA-B, HLA-DRB1 Low/Intermediate Resolution Typing
CPT code 81371 identifies a molecular laboratory procedure for low- or intermediate-resolution typing of human leukocyte antigen genes at Class I loci HLA–A and HLA–B and Class II locus HLA–DRB1. This HLA panel is used in clinical contexts where matching for transplantation, donor selection, disease association studies, or immune-risk assessment is needed. Nationally, standardized reporting of HLA results and correct coding of molecular diagnostics are important for claims consistency, lab reimbursement, and clinical decision support.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose and technical scope of the test, typical sites of service, and payer coverage considerations. The publication summarizes coding context, common modifiers associated with laboratory services, and what to expect in payer interactions. It also provides benchmarks for utilization and reimbursement patterns where available and highlights recent policy updates relevant to molecular HLA testing.
This summary is intended for laboratory billing staff, coding professionals, and clinical teams seeking a clear, national-level briefing on CPT code 81371.
Billing Code Overview
CPT code 81371 describes a molecular laboratory test for low- or intermediate-resolution assessment of human leukocyte antigen (HLA) genes. The test analyzes Class I loci HLA–A and HLA–B, and Class II locus HLA–DRB1 using molecular techniques performed by a laboratory analyst.
Service type: Molecular pathology / HLA typing (technical laboratory component)
Typical site of service: Clinical laboratory or molecular diagnostics laboratory (ambulatory or hospital-based laboratory setting)
Clinical & Coding Specifications
Clinical Context
A 35-year-old adult with end-stage renal disease is undergoing evaluation for kidney transplantation. The transplant center orders HLA typing to assess donor–recipient compatibility. A peripheral blood sample is collected in the outpatient phlebotomy clinic and sent to the molecular diagnostics laboratory. The laboratory technologist performs 81371 to determine low- or intermediate-resolution HLA typing for Class I loci HLA-A and HLA-B and Class II locus HLA-DRB1. Results are reported to the transplant team and entered into the organ allocation record to guide donor selection, crossmatch interpretation, and immunologic risk assessment. Typical sites of service include outpatient phlebotomy clinics, hospital laboratory services, reference molecular diagnostic laboratories, and transplant center labs. The patient encounter typically involves pre-transplant evaluation, donor workup, or compatibility assessment for living or deceased donor organ transplantation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component separate from the technical lab processing when applicable. |